Predicting short term response to anti-inflammatory therapy in young children with asthma

References

• Carlsen KH. What distinguishes the asthmatic amongst the infant wheezers?. Pediatr Allergy Immunol 1997;8(10 Suppl.):40-5
   PubMedGoogle Scholar
• Martinez FD, Wright AL, Taussig LM, et al. Asthma and wheezing in the first six years of life. The Group Health Medical Associates. N Engl J Med 1995;332:133-8
   PubMed Web of Science ®Google Scholar
• Reichenbach J, Jarisch A, Khan S, et al. Serum ECP levels and methacholine challenge in infants with recurrent wheezing. Ann Allergy Asthma Immunol 2002;89:498-502
   PubMed Web of Science ®Google Scholar
• Kurukulaaratchy RJ, Matthews S, Holgate ST, et al. Predicting persistent disease among children who wheeze during early life. Eur Respir J 2003;22:767-71
   PubMed Web of Science ®Google Scholar
• Bisgaard H, Zielen S, Garcia-Garcia ML, et al. Montelukast reduces asthma exacerbations in 2- to 5-year-old children with intermittent asthma. Am J Respir Crit Care Med 2005;171:315-22
   PubMed Web of Science ®Google Scholar
• Knorr B, Franchi LM, Bisgaard H, et al. Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years. Pediatrics 2001;108:E48
   PubMed Web of Science ®Google Scholar
• Zeiger RS, Bird SR, Kaplan MS, et al. Short-term and long-term asthma control in patients with mild persistent asthma receiving montelukast or fluticasone: a randomized controlled trial. Am J Med 2005;118:649-57
   PubMed Web of Science ®Google Scholar
• Bateman ED, Hurd SS, Barnes PJ, et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 2008;31:143-78
   PubMed Web of Science ®Google Scholar
• National Asthma Education and Prevention Program. Export Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma – Summary Report 2007. J Allergy Clin Immunol 2007;120(5 Suppl.):S94-138
   PubMed Web of Science ®Google Scholar
• Ostrom NK, Decotiis BA, Lincourt WR, et al. Comparative efficacy and safety of low-dose fluticasone propionate and montelukast in children with persistent asthma. J Pediatr 2005;147:213-20
   PubMed Web of Science ®Google Scholar
• Sorkness CA, Lemanske RF Jr, Mauger DT, et al. Long-term comparison of 3 controller regimens for mild–moderate persistent childhood asthma: the Pediatric Asthma Controller Trial. J Allergy Clin Immunol 2007;119:64-72
   PubMed Web of Science ®Google Scholar
• Stempel DA, Kruzikas DT, Manjunath R. Comparative efficacy and cost of asthma care in children with asthma treated with fluticasone propionate and montelukast. J Pediatr 2007;150:162-7
   PubMed Web of Science ®Google Scholar
• Zeiger RS, Szefler SJ, Phillips BR, et al. Response profiles to fluticasone and montelukast in mild-to-moderate persistent childhood asthma. J Allergy Clin Immunol 2006;117:45-52
   PubMed Web of Science ®Google Scholar
• Szefler SJ, Phillips BR, Martinez FD, et al. Characterization of within-subject responses to fluticasone and montelukast in childhood asthma. J Allergy Clin Immunol 2005;115:233-42
   PubMed Web of Science ®Google Scholar
• Arets HG, Kamps AW, Brackel HJ, et al. Children with mild asthma: do they benefit from inhaled corticosteroids?. Eur Respir J 2002;20:1470-5
   PubMed Web of Science ®Google Scholar
• Schokker S, Kooi EM, de Vries TW, et al. Inhaled corticosteroids for recurrent respiratory symptoms in pre-school children in general practice: randomized controlled trial. Pulm Pharmacol Ther 2008;21:88-97
   PubMed Web of Science ®Google Scholar
• Martin RJ, Szefler SJ, King TS, et al. The Predicting Response to Inhaled Corticosteroid Efficacy (PRICE) trial. J Allergy Clin Immunol 2007;119:73-80
   PubMed Web of Science ®Google Scholar
• Santanello NC, Demuro-Mercon C, Davies G, et al. Validation of a pediatric asthma caregiver diary. J Allergy Clin Immunol 2000;106:861-6
   PubMed Web of Science ®Google Scholar
• Quanjer PH, Borsboom GJ, Brunekreef B, et al. Spirometric reference values for white European children and adolescents: Polgar revisited. Pediatr Pulmonol 1995;19:135-42
   PubMed Web of Science ®Google Scholar
• Recommendations for standardized procedures for the on-line and off-line measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide in adults and children – 1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors. Am J Respir Crit Care Med 1999;160:2104-17
   PubMedGoogle Scholar
• Crapo RO, Casaburi R, Coates AL, et al. Guidelines for methacholine and exercise challenge testing – 1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med 2000;161:309-29
   PubMed Web of Science ®Google Scholar
• , American Lung Association Asthma Clinical Research CentersPeters SP, Anthonisen N, et al. Randomized comparison of strategies for reducing treatment in mild persistent asthma. N Engl J Med 2007;356:2027-39
   PubMed Web of Science ®Google Scholar
• Bacharier LB, Boner A, Carlsen K, et al. Diagnosis and treatment of asthma in childhood: a PRACTALL consensus report. Allergy 2008;63:5-34
   PubMed Web of Science ®Google Scholar
• Saglani S, Malmström K, Pelkonen AS, et al. Airway remodeling and inflammation in symptomatic infants with reversible airflow obstruction. Am J Respir Crit Care Med 2005;171:722-7
   PubMed Web of Science ®Google Scholar
• Le Bourgeois M, Goncalves M, Le Clainche L, et al. Bronchoalveolar cells in children < 3 years old with severe recurrent wheezing. Chest 2002;122:791-7
   PubMed Web of Science ®Google Scholar
• Marguet C, Jouen-Boedes F, Dean TP, et al. Bronchoalveolar cell profiles in children with asthma, infantile wheeze, chronic cough, or cystic fibrosis. Am J Respir Crit Care Med 1999;159(5 Pt 1):1533-40
   PubMed Web of Science ®Google Scholar
• Saglani S, Payne DN, Zhu J, et al. Early detection of airway wall remodeling and eosinophilic inflammation in pre-school wheezers. Am J Respir Crit Care Med 2007;176:858-64
   PubMed Web of Science ®Google Scholar
• Garcia Garcia ML, Wahn U, Gilles L, et al. Montelukast, compared with fluticasone, for control of asthma among 6- to 14-year-old patients with mild asthma: the MOSAIC study. Pediatrics 2005;116:360-9
   PubMed Web of Science ®Google Scholar
• Guilbert TW, Morgan WJ, Zeiger RS, et al. Long-term inhaled corticosteroids in pre-school children at high risk for asthma. N Engl J Med 2006;354:1985-97
   PubMed Web of Science ®Google Scholar
• Wasserman RL, Baker JW, Kim KT, et al. Efficacy and safety of inhaled fluticasone propionate chlorofluorocarbon in 2- to 4-year-old patients with asthma: results of a double-blind, placebo-controlled study. Ann Allergy Asthma Immunol 2006;96:808-18
   PubMed Web of Science ®Google Scholar
• Johnston NW, Mandhane PJ, Dai J, et al. Attenuation of the September epidemic of asthma exacerbations in children: a randomized, controlled trial of montelukast added to usual therapy. Pediatrics 2007;120:e702-12
   PubMed Web of Science ®Google Scholar
• Kooi EM, Schokker S, Marike Boezen H, et al. Fluticasone or montelukast for pre-school children with asthma-like symptoms: randomized controlled trial. Pulm Pharmacol Ther 2008;21:798-804
   PubMed Web of Science ®Google Scholar
• Beydon N, Davis SD, Lombardi E, et al. An official American Thoracic Society/European Respiratory Society statement: pulmonary function testing in preschool children. Am J Respir Crit Care Med 2007;175:1304-45
   PubMed Web of Science ®Google Scholar
• Nystad W, Samuelsen SO, Nafstad P, et al. Feasibility of measuring lung function in preschool children. Thorax 2002;57:1021-7
   PubMed Web of Science ®Google Scholar
• Simpson A, Soderstrom L, Ahlstedt S, et al. IgE antibody quantification and the probability of wheeze in pre-school children. J Allergy Clin Immunol 2005;116:744-9
   PubMed Web of Science ®Google Scholar
• Rabinovitch N, Strand M, Stuhlman K, et al. Exposure to tobacco smoke increases leukotriene E4-related albuterol usage and response to montelukast. J Allergy Clin Immunol 2008;121:1365-71
   PubMed Web of Science ®Google Scholar
• Jartti T. Inhaled corticosteroids or montelukast as the preferred primary long-term treatment for pediatric asthma?. Eur J Pediatr 2008;167:731-6
   PubMed Web of Science ®Google Scholar
• Pauwels RA, Pedersen S, Busse WW, et al. Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trial. Lancet 2003;361:1071-6
   PubMed Web of Science ®Google Scholar
• Fuhlbrigge AL, Weiss ST, Kuntz KM, et al. Forced expiratory volume in 1 second percentage improves the classification of severity among children with asthma. Pediatrics 2006;118:e347-55
   PubMed Web of Science ®Google Scholar
• Halterman JS, Szilagyi PG, Yoos HL, et al. Benefits of a school-based asthma treatment program in the absence of secondhand smoke exposure: results of a randomized clinical trial. Arch Pediatr Adolesc Med 2004;158:460-7
   PubMed Web of Science ®Google Scholar
• Lazarus SC, Chinchilli VM, Rollings NJ, et al. Smoking affects response to inhaled corticosteroids or leukotriene receptor antagonists in asthma. Am J Respir Crit Care Med 2007;175:783-90
   PubMed Web of Science ®Google Scholar